![]() |
市場調查報告書
商品編碼
2056482
細胞分離技術市場規模、佔有率、趨勢和預測:按產品、細胞類型、技術、應用、最終用戶和地區分類,2026-2034年Cell Separation Technologies Market Size, Share, Trends and Forecast by Product, Cell Type, Technology, Application, End User, and Region, 2026-2034 |
||||||
2025年全球細胞分離技術市場規模為134億美元。展望未來,IMARC Group預測,該市場將在2026年至2034年間以12.01%的複合年成長率成長,到2034年達到383億美元。目前,北美市場佔據主導地位,預計2025年市佔率將超過40.0%。推動市場成長的主要因素包括:製藥和生物技術領域對細胞分離技術的日益普及、個人化醫療需求的成長以及產業技術的不斷進步。
細胞分離技術,或稱為細胞分離技術,是指用於從異質細胞混合物中分離特定細胞的一系列方法和技術。代表性技術包括微流體細胞分選、螢光活化細胞分選 (FACS)、免疫抗原性細胞分離、磁活化細胞分選 (MACS) 和密度梯度離心法。細胞分離技術可用於分離稀有癌細胞和幹細胞,以進行後續分析和治療。因此,這些技術廣泛應用於醫療和生物技術產業的研究、臨床和工業領域,例如疾病診斷、藥物研發和生物製程。此外,細胞分離技術對於研究細胞異質性、理解疾病機制和開發個人化醫療也至關重要。
細胞分離技術在製藥業中日益廣泛的應用,是推動藥物發現和開發流程的關鍵因素,也是市場成長的主要驅動力。同時,包括癌症、後天免疫力缺乏缺乏症候群(AIDS)和囊腫纖維化在內的多種慢性疾病和感染疾病的盛行率不斷上升。此外,對個人化和再生醫學日益成長的需求,也增加了對能夠分離特定細胞類型以進行標靶治療的高精度細胞分離技術的需求。另外,細胞分離技術在包括人類乳突病毒(HPV)、流感和輪狀病毒在內的多種疾病疫苗生產中的廣泛應用,也為市場創造了良好的前景。此外,蓬勃發展的生物技術領域對研發的大量投入,用於開發新型細胞治療方法和治療方法,也促進了市場成長。同時,對幹細胞研究的日益關注、體外診斷需求的激增以及政府為改善醫療基礎設施而採取的多項支持措施,也都在推動市場擴張。此外,細胞分離技術的不斷進步,例如微流體技術、晶片實驗室和微陣列技術,正為市場創造盈利的成長機會。能夠對核酸、染色質、蛋白質和其他複雜細胞進行連續檢測的先進分離工具的出現,是推動市場成長的另一個關鍵因素。
本報告分析了全球細胞分離技術市場各細分領域的關鍵趨勢,並對2026年至2034年進行了全球、區域和國家層面的預測。市場按產品、細胞類型、技術、應用和最終用戶進行細分。
此外,本報告對所有主要區域市場進行了全面分析,包括北美(美國和加拿大)、亞太地區(中國、日本、印度、韓國、澳洲、印尼等)、歐洲(德國、法國、英國、義大利、西班牙、俄羅斯等)、拉丁美洲(巴西、墨西哥等)以及中東和非洲。報告指出,北美是細胞分離技術最大的市場。推動北美細胞分離技術市場發展的因素包括製藥業的強勁成長、個人化醫療需求的不斷增加以及分離工具的持續進步。
本報告對全球細胞分離技術市場的競爭格局進行了全面分析。報告內容包括市場結構、主要參與者的市場佔有率、公司定位、關鍵成功策略、競爭格局概覽、公司評估象限等競爭分析。報告還提供了主要參與者的詳細公司簡介。報告中涵蓋的公司包括 Akadeum Life Sciences、Alfa Laval AB、Becton, Dickinson and Company、Bio-Rad Laboratories Inc.、Corning Incorporated、Merck KGaA、Miltenyi Biotec Inc.、PerkinElmer Inc.、pluri Life Science UG (haftungsbeschran) & Co. K.xrumr.以上僅為部分公司名單,完整名單請參閱完整報告。
The global cell separation technologies market size was valued at USD 13.4 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 38.3 Billion by 2034, exhibiting a CAGR of 12.01% during 2026-2034. North America currently dominates the market, holding a significant market share of over 40.0% in 2025. The rising adoption of cell separation technologies across the pharmaceutical and biotechnology sectors, the growing demand for personalized medicine, and ongoing technological advancements in the industry represent some of the key factors driving the market.
Cell separation technologies, or cell isolation technologies, refer to a range of methods and techniques used to isolate specific cells from a heterogeneous mixture of cells. Some of the standard techniques include microfluidic cell sorting, fluorescence-activated cell sorting (FACS), immunogenicity cell isolation, magnetic-activated cell sorting (MACS), and density gradient configuration. Cell separation technologies help isolate rare tumor cells or stem cells for further analysis and therapeutic purposes. As a result, they are used across the healthcare and biotechnology industries for research, clinical, and industrial applications, such as disease diagnosis, drug discovery, and bioprocessing. In addition to this, cell separation technologies are essential for studying cellular heterogeneity to understand disease mechanisms and develop personalized medicines.
The increasing use of cell separation technologies across the pharmaceutical industry to enhance drug discovery and development procedures represents the primary factor driving the market growth. In line with this, the growing prevalence of numerous chronic and infectious diseases, such as cancer, acquired immune deficiency syndrome (AIDS), and cystic fibrosis, is propelling the market growth. Moreover, the increasing demand for personalized and regenerative medicines is fueling the need for highly specific cell separation technologies that can isolate specific cell types for targeted therapy. Besides this, the widespread utilization of cell separation technologies in manufacturing vaccines for various diseases, including human papillomavirus (HPV), influenza, and rotavirus, is creating a favorable outlook for the market. In addition to this, extensive investments in research and development (R&D) initiatives in the flourishing biotechnology sector for developing novel cell-based treatments and therapies are contributing to the market growth. Concurrent with this, an intensive focus on stem cell research, the surging demand for in vitro diagnostics, and the implementation of numerous favorable initiatives undertaken by governments of various countries to improve healthcare infrastructure are aiding in market expansion. Furthermore, ongoing technological advancements in cell separation technologies, such as microfluidics, lab-on-a-chip, and microarray technologies, are presenting remunerative growth opportunities for the market. Furthermore, the advent of advanced isolation tools that allows continuous examination of nucleic acids, chromatin, proteins, and other complex cells is acting as another significant growth-inducing factor.
This report provides an analysis of the key trends in each segment of the global cell separation technologies market, along with forecasts at the global, regional, and country levels from 2026-2034. The market has been categorized based on product, cell type, technology, application, and end user.
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for cell separation technologies. Some of the factors driving the North America cell separation technologies market included the bolstering growth of the pharmaceutical industry, the rising demand for personalized medicines, and the ongoing advancements in isolation tools.
The report has also provided a comprehensive analysis of the competitive landscape in the global cell separation technologies market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Akadeum Life Sciences, Alfa Laval AB, Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Corning Incorporated, Merck KGaA, Miltenyi Biotec Inc., PerkinElmer Inc., pluriSelect Life Science UG (haftungsbeschrankt) & Co. KG, Stemcell Technologies Inc., Terumo Corporation and Thermo Fisher Scientific Inc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.